1,212
Participants
Start Date
November 30, 2015
Primary Completion Date
February 7, 2017
Study Completion Date
May 12, 2017
CD5789 (trifarotene) 50µg/g Cream
CD5789 (Trifarotene) 50µg/g cream applied once daily during 12 weeks.
Placebo Cream
Placebo cream applied once daily during 12 weeks.
Galderma Investigational Site, Budapest
Galderma Investigational Site, Budapest
Galderma Investigational Site, Miskolc
Galderma Investigational Site, Debrecen
Galderma Investigational Site, Szolnok
Galderma Investigational Site, Szeged
Galderma Investigational Site, Pécs
Galderma Investigational Site, Esplugues de Llobregat
Galderma Investigational Site, Brooklyn
Galderma Investigational Site, Stony Brook
Galderma Investigational Site, Fort Washington
Galderma Investigational Site, Philadelphia
Galderma Investigational site, Madrid
Galderma Investigational Site, Wilmington
Galderma Investigational Site, Greer
Galderma Investigational Site, Miami Lakes
Galderma Investigational Site, Miami
Galderma Investigational Site, Aventura
Galderma Investigational Site, West Palm Beach
Galderma Investigational Site, Birmingham
Galderma Investigational Site, Goodlettsville
Galderma Investigational Site, Corbin
Galderma Investigational Site, Valencia
Galderma Investigational Site, Ann Arbor
Galderma Investigational Site, Detroit
Galderma Investigational Site, Dnipropetrovsk
Galderma Investigational Site, Dnipropetrovsk
Galderma Investigational Site, Kharkiv
Galderma Investigational Site, Fort Smith
Galderma Investigational Site, Ivano-Frankivsk
Galderma Investigational Site, Houston
Galderma Investigational Site, Webster
Galderma Investigational Site, San Antonio
Galderma Investigational Site, Pflugerville
Galderma Investigational Site, Lviv
Galderma Investigational Site, Phoenix
Galderma Investigational Site, Tucson
Galderma Investigational Site, Uzhhorod
Galderma Investigational Site, Los Angeles
Galderma Investigational Site, Murrieta
Galderma Investigational Site, Santa Ana
Galderma Investigational Site, Walla Walla
Galderma Investigational Site, Moscow
Galderma Investigational Site, Moscow
Galderma Investigational Site, Moscow
Galderma Investigational Site, Sr Petersburg
Galderma Investigational Site, Saint Petersburg
Galderma Investigational Site, Craiova
Galderma Investigational Site, Lipetsk
Galderma Investigational Site, Brasov
Galderma Investigational Site, Târgu Mureş
Galderma Investigational Site, Iași
Galderma Investigational Site, Beverly
Galderma Invetsigational site, Austin
Galderma Investigational Site, Dallas
Galderma Investigational Site, Chomutov
Galderma Investigational Site, Hradec Králové
Galderma Investigational Site, Kutná Hora
Galderma Investigational Site, Olomouc
Galderma Investigational Site, Pardubice
Galderma Investigational Site, Prague
Galderma Investigational Site, Prague
Galderma Investigational Site, Prague
Galderma Investigational Site, Bialystok
Galderma Investigational Site, Gdansk
Galderma Investigational Site, Gdansk
Galderma Investigational Site, Gdansk
Galderma Investigational Site, Katowice
Galderma investigational Site, Katowice
Galderma Investigational Site, Katowice
Galderma Investigational Site, Lodz
Galderma Investigational Site, Sochaczew
Galderma Investigational Site, Warsaw
Galderma investigational Site, Warsaw
Galderma Investigational Site, Warsaw
Galderma Investigational Site, Wroclaw
Galderma Investigational Site, Wroclaw
Galderma Investigational Site, Krasnodar
Galderma Investigational Site, Barcelona
Galderma Investigational Site, Kyiv
Galderma Investigational Site, Kyiv
Lead Sponsor
Galderma R&D
INDUSTRY